Similarly, increased p-PPAR-γ/PTEN with decreased p38/ATF2/UCP1 was demonstrated in the peripheral NK cells of patients with advanced NAFLD (Fig. 7B). This evidence concerns the gene MAPK14 and metabolic dysfunction-associated steatotic liver disease.